Cite
Shi J, Xiao J, Wang X, et al. Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism. Clin Pharmacol Ther. 2021;doi: 10.1002/cpt.2486.
Shi, J., Xiao, J., Wang, X., Jung, S. M., Bleske, B. E., Markowitz, J. S., Patrick, K. S., & Zhu, H. J. (2021). Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism. Clinical pharmacology and therapeutics, . https://doi.org/10.1002/cpt.2486
Shi, Jian, et al. "Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism." Clinical pharmacology and therapeutics vol. (2021). doi: https://doi.org/10.1002/cpt.2486
Shi J, Xiao J, Wang X, Jung SM, Bleske BE, Markowitz JS, Patrick KS, Zhu HJ. Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism. Clin Pharmacol Ther. 2021 Nov 07; doi: 10.1002/cpt.2486. Epub 2021 Nov 07. PMID: 34743324.
Copy
Download .nbib